RAM
PTLA

Riggs Asset Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Riggs Asset Management’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-239
Closed -$9K – 333
2015
Q1 		$9K Buy
+239
New +$8.21K ﹤0.01% 221

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Riggs Asset Management's PTLA Position: Q2 2015 in Review

Riggs Asset Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q2 2015, closing a stake of 239 shares — an estimated $9K sold.

Riggs Asset Management first reported a position in PTLA in Q1 2015 and held it in 1 quarter. The position peaked at $9K in Q1 2015. 160 funds tracked by Wall St. Rank hold PTLA as of Q2 2015.

  • Riggs Asset Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q2 2015 after selling out during the quarter.
  • Riggs Asset Management sold 239 Portola Pharmaceuticals, Inc. shares in Q2 2015, an estimated $9K.
  • Riggs Asset Management first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 1 quarter.
  • Riggs Asset Management's Portola Pharmaceuticals, Inc. position peaked at $9K in Q1 2015.
  • 160 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q2 2015.

Based on Riggs Asset Management's 13F filing for Q2 2015, filed 4 Aug 2015.